104 related articles for article (PubMed ID: 19204928)
21. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads.
Schmierer B; Hill CS
Mol Cell Biol; 2005 Nov; 25(22):9845-58. PubMed ID: 16260601
[TBL] [Abstract][Full Text] [Related]
22. Model system to study classical nuclear export signals.
Kanwal C; Li H; Lim CS
AAPS PharmSci; 2002; 4(3):E18. PubMed ID: 12423067
[TBL] [Abstract][Full Text] [Related]
23. EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis.
Faitar SL; Sossey-Alaoui K; Ranalli TA; Cowell JK
Exp Cell Res; 2006 Jul; 312(12):2325-35. PubMed ID: 16764853
[TBL] [Abstract][Full Text] [Related]
24. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.
Sen S; Zhou H; White RA
Oncogene; 1997 May; 14(18):2195-200. PubMed ID: 9174055
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of wild-type p53 gene on excessive replication of centrosomes in leukemia cell line K562.
Tian WJ; Feng WL; Wang HB; Huang SF; Cao WX; Huang ZG
Ai Zheng; 2009 Feb; 28(2):122-6. PubMed ID: 19550118
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Aurora A on biological phenotypes of prostate cancer cells].
Zhao FY; Qu Y; Zhang L; Mu DZ; Huang X; Wei DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):302-5. PubMed ID: 17441355
[TBL] [Abstract][Full Text] [Related]
27. RASSF1A interacts with and activates the mitotic kinase Aurora-A.
Liu L; Guo C; Dammann R; Tommasi S; Pfeifer GP
Oncogene; 2008 Oct; 27(47):6175-86. PubMed ID: 18641684
[TBL] [Abstract][Full Text] [Related]
28. STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma.
Li Y; Li F; Li-Ling J; Wang X; Xu Z; Sun K
Cancer Invest; 2005; 23(8):660-4. PubMed ID: 16377583
[TBL] [Abstract][Full Text] [Related]
29. Analysis of nuclear export using photoactivatable GFP fusion proteins and interspecies heterokaryons.
Nakrieko KA; Ivanova IA; Dagnino L
Methods Mol Biol; 2010; 647():161-70. PubMed ID: 20694666
[TBL] [Abstract][Full Text] [Related]
30. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy.
Johnson EO; Chang KH; Ghosh S; Venkatesh C; Giger K; Low PS; Shah K
J Cell Sci; 2012 Mar; 125(Pt 5):1204-16. PubMed ID: 22492986
[TBL] [Abstract][Full Text] [Related]
31. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.
Du J; Hannon GJ
Nucleic Acids Res; 2002 Dec; 30(24):5465-75. PubMed ID: 12490715
[TBL] [Abstract][Full Text] [Related]
32. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet R; Petretti C; Prigent C
Trends Cell Biol; 2005 May; 15(5):241-50. PubMed ID: 15866028
[TBL] [Abstract][Full Text] [Related]
33. IQGAP1 interacts with Aurora-A and enhances its stability and its role in cancer.
Yin N; Shi J; Wang D; Tong T; Wang M; Fan F; Zhan Q
Biochem Biophys Res Commun; 2012 Apr; 421(1):64-9. PubMed ID: 22483753
[TBL] [Abstract][Full Text] [Related]
34. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
[TBL] [Abstract][Full Text] [Related]
35. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S
Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305
[TBL] [Abstract][Full Text] [Related]
36. Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer.
Tseng YS; Tzeng CC; Huang CY; Chen PH; Chiu AW; Hsu PY; Huang GC; Wang YC; Liu HS
Cancer Lett; 2006 Sep; 241(1):93-101. PubMed ID: 16338065
[TBL] [Abstract][Full Text] [Related]
37. Suppression of Aurora-A oncogenic potential by c-Myc downregulation.
Yang S; He S; Zhou X; Liu M; Zhu H; Wang Y; Zhang W; Yan S; Quan L; Bai J; Xu N
Exp Mol Med; 2010 Nov; 42(11):759-67. PubMed ID: 20890087
[TBL] [Abstract][Full Text] [Related]
38. Localization of aurora A and aurora B kinases during interphase: role of the N-terminal domain.
Rannou Y; Troadec MB; Petretti C; Hans F; Dutertre S; Dimitrov S; Prigent C
Cell Cycle; 2008 Oct; 7(19):3012-20. PubMed ID: 18802402
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis.
Tatsuka M; Sato S; Kitajima S; Suto S; Kawai H; Miyauchi M; Ogawa I; Maeda M; Ota T; Takata T
Oncogene; 2005 Feb; 24(6):1122-7. PubMed ID: 15592510
[TBL] [Abstract][Full Text] [Related]
40. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
